Page last updated: 2024-10-29

imipramine and Diffuse Parenchymal Lung Disease

imipramine has been researched along with Diffuse Parenchymal Lung Disease in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Research Excerpts

ExcerptRelevanceReference
"Since pulmonary fibrosis is a recognized, if rare, complication of certain drug exposures, including antidepressants, betablockers, antibiotics, anticonvulsants, and nonsteroidal antiinflammatory drugs (NSAIDs), we tested the hypothesis that exposure to these drugs might contribute to the etiology of cryptogenic fibrosing alveolitis."1.30Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study. ( Britton, J; Cooper, M; Hubbard, R; Johnston, I; Smith, C; Venn, A, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hubbard, R1
Venn, A1
Smith, C1
Cooper, M1
Johnston, I1
Britton, J1

Other Studies

1 other study available for imipramine and Diffuse Parenchymal Lung Disease

ArticleYear
Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.
    American journal of respiratory and critical care medicine, 1998, Volume: 157, Issue:3 Pt 1

    Topics: Adrenergic beta-Antagonists; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; A

1998